New Integrase Inhibitors RAL, EVG and DTG improving the efficacy of ARVs in controlling HIV replication by providing personalized therapy.
Continue readingStudy: New HIV Integrase Inhibitors RAL, EVG and DTG
Posts Tagged → #intergraseinhibitor
New Integrase Inhibitors Better In Controlling HIV Replication than Other Antiretrovirals
Availability of new integrase inhibitors offers better opportunities to improve efficiency of cART and PEP in controlling HIV replication.
Continue readingHIV PEP drugs: Isentress® (Raltegravir) intergrase inhibitor
Isentress® is one of the newest classes of antiretrovirals, the intergrase inhibitors. This drug disables the HIV intergrase protein which is responsible for integrating the viral genome into the human chromosome and causing the chronic incurable infection. Developed by Merck and Co, it was approved for adult use in 2007 by the FDA and use… Continue reading